...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Review of ZCC history
Reply New Message
Prev Message Back To Forum Threaded View Next Message

You are right about RVX NR stating next year , ( not early next year,) must have been my unbridled over enthusiam lol....  Can't trust any forward looking statement out of DM's mouth , How about DM  shocking  the market on any deal with Zenith at this point ... waiting patiently.....

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply